Breaking News
EDUCATIONAL WEBINAR FOR PATIENTS ON IRON OVERLOAD AND MONITORING | 21 November 2024
SICKLE CELL DISEASE | FDA Grants Orphan Drug Designation to AND017
TIF STUDY | Desferioxamine Usage Survey
COUNTRIES | The Maldives Launches Thalassaemia-Specialized Hospital and 10-Year Strategic Disease Plan
Splenectomy as Treatment for Primary Warm Autoimmune Hemolytic Anemia (wAIHA)
WHAT YOU NEED TO KNOW | EMA Recommends Suspension of Pfizer’s Sickle Cell Disease Drug Oxbryta
APLASTIC ANEMIA | Hetrombopag Achieves Significant Hematological Responses in Newly Diagnosed Patients
THALASSAEMIA WEBINAR FOR ASEAN & OCEANIA HEALTHCARE PROFESSIONALS | 21 October 2024
UNITING EXPERTS | Highlights from the 1st Nordic Red Blood Cell Meeting
ANNUAL REPORT 2023 | Unveiling TIF’s Impactful Achievements
English
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
Projects
/
Ongoing projects
Ongoing projects
August 30, 2022
Mental Health Impact of COVID-19 in Thalassaemia Patients
Read More »
February 16, 2021
TIF.ACCESS Project
Read More »
November 14, 2019
TIF’s Patient Advocacy Group (T-PAG)
Read More »
April 14, 2021
Rare Anaemias International Network (RAIN)
Read More »
December 5, 2018
TIF Certification Programme
Read More »
June 1, 2024
THALIA2024 Project
Read More »
January 14, 2022
TIF’s Cost of Illness Model
Read More »
October 12, 2021
International Sickle Cell Disease Active Group (IASG)
Read More »
Back to top button
Close
Search for